Key results from the interim analysis of the Phase 3 ENLIGHTED study of Padeliporfin VTP: As of November 5, 2024, the data cut-off for the poster presentation at ASCO, 43 patients had begun treatment, ...

The BREAKWATER study enrolled patients with newly diagnosed colon cancer that harbors a mutation called BRAF 600E that makes ...

Billionaire entrepreneur Bryan Johnson reveals his audacious goal to live till 2140 to witness Bitcoin's last halving, ...

I n her State of the City address in March, Mayor Michelle Wu spoke about her then-2-month-old daughter. The world she ...

Another factor that may be contributing to the decline in publishing by industry medicinal chemists is the fact that ...

Mettler-Toledo’s capital efficiency, strong moat, and robust free cash flow make it a standout investment. Click here to find ...

Ben Stiller and Adam Scott dish on 'Severance' Season 3, potential spinoffs and rumors of chaos behind the scenes.

REVEAL GENOMICS, S.L., a biotechnology company advancing precision oncology through biomarker innovation, today announced the ...

Aroa Biosurgery shares have gained up to 16% on full-year results that exceeded guidance and restored the company to profitability ...

Equity Insider News Commentary – With early onset cancer rates on the rise and funding being cut to NIH, the future for cancer patients is increasingly being shaped not by public institutions, but by ...